DR. LAWRENCE DEAN PETZ, M.D.
Osteopathic Medicine at Anadale Dr, Los Angeles, CA
License number
California G5536
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
19633 Anadale Dr, Los Angeles, CA 91356
Phone
(818) 996-4133
Personal information
See more information about LAWRENCE DEAN PETZ at radaris.comName
Address
Phone
19633 Anadale Dr, Tarzana, CA 91356
Reseda, CA
19633 Anadale Dr, Tarzana, CA 91356
Professional information
Dr. Lawrence D Petz, Tarzana CA - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
19633 Anadale Dr, Tarzana 91356
(818) 996-4133 (Phone), (818) 996-4133 (Fax)
(818) 996-4133 (Phone), (818) 996-4133 (Fax)
Certifications:
Hematology, 1974, Internal Medicine, 1974
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
19633 Anadale Dr, Tarzana 91356
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1955
Cook Co Hosp
San Francisco General Hospital
San Francisco Va Hosp
University of Illinois At Chicago / College of Medicine
Graduated: 1955
Cook Co Hosp
San Francisco General Hospital
San Francisco Va Hosp
Medical Director At Stemcyte Internationsl Cord Blood Center
Position:
Medical Director at StemCyte Internationsl Cord Blood Center
Location:
Greater Los Angeles Area
Industry:
Medical Practice
Work:
StemCyte Internationsl Cord Blood Center
-
Medical Director
Stem Cell Screening And Transplantation Therapy For Hiv Infection
US Patent:
2005022, Oct 6, 2005
Filed:
Nov 27, 2002
Appl. No.:
10/498450
Inventors:
Robert Chow - Arcadia CA, US
Denis Rodgerson - Malibu CA, US
Rubio Punzalan - Torrance CA, US
Lawrence Petz - Tarzana CA, US
Denis Rodgerson - Malibu CA, US
Rubio Punzalan - Torrance CA, US
Lawrence Petz - Tarzana CA, US
Assignee:
SternCyte, Inc. - Arcadia CA
International Classification:
A61K048/00
US Classification:
424093210
Abstract:
This invention provides methods for preventing or treating any disease arising from HIV infection, including AIDS and AIDS-related complex (ARC). The method comprises screening a plurality of donors to identify stem cells with a beneficial gene or genes and then transplanting the therapeutic stem cells into a patient. In preferred embodiments, the beneficial gene encodes a polymorphism that renders cells refractory to HIV infection. The polymorphism may be for a gene that encodes a ligand of a receptor for HIV entry, a product of the HLA complex, or a receptor for HIV entry. The Invention also provides isolated populations of stem cells with beneficial genes for resisting infections.
Undesignated Allogeneic Stem Cell Bank
US Patent:
2003021, Nov 20, 2003
Filed:
Feb 13, 2003
Appl. No.:
10/367339
Inventors:
Robert Chow - Arcadia CA, US
Lawrence Petz - Tarzana CA, US
Rubio Punzalan - Torrance CA, US
Denis Rodgerson - Malibu CA, US
Lawrence Petz - Tarzana CA, US
Rubio Punzalan - Torrance CA, US
Denis Rodgerson - Malibu CA, US
Assignee:
STEMCYTE, Inc. - Arcadia CA
International Classification:
A61K045/00, C12N005/08
US Classification:
435/366000, 435/372000, 424/093700
Abstract:
This invention provides methods for supplying a therapy for individuals exposed to radiation following a nuclear event, through the prospective establishment of an undesignated allogeneic stem cell bank with prospective HLA typing of healthy potential recipients.
Stem Cell Screening And Transplantation Therapy For Hiv Infection
US Patent:
2003009, May 29, 2003
Filed:
Nov 29, 2001
Appl. No.:
09/998832
Inventors:
Robert Chow - Arcadia CA, US
Denis Rodgerson - Malibu CA, US
Rubio Punzalan - Torrance CA, US
Lawrence Petz - Tarzana CA, US
Denis Rodgerson - Malibu CA, US
Rubio Punzalan - Torrance CA, US
Lawrence Petz - Tarzana CA, US
International Classification:
A61K048/00, C12N005/08, C12N015/85
US Classification:
424/093210, 435/372000, 435/455000
Abstract:
This invention provides methods for preventing or treating any disease arising from HIV infection, including AIDS and AIDS-related complex (ARC). The method comprises screening a plurality of donors to identify stem cells with a beneficial gene or genes and then transplanting the therapeutic stem cells into a patient. In preferred embodiments, the beneficial gene encodes a polymorphism that renders cells refractory to HIV infection. The polymorphism may be for a gene that encodes a ligand of a receptor for HIV entry, a product of the HLA complex, or a receptor for HIV entry.
Allogeneic Stem Cell Bank
US Patent:
2011017, Jul 14, 2011
Filed:
Oct 20, 2010
Appl. No.:
12/908143
Inventors:
Robert Chow - Arcadia CA, US
Lawrence D. Petz - Tarzana CA, US
Rubio R. Punzalan - Torrance CA, US
Denis O. Rodgerson - Malibu CA, US
Lawrence D. Petz - Tarzana CA, US
Rubio R. Punzalan - Torrance CA, US
Denis O. Rodgerson - Malibu CA, US
Assignee:
StemCyte, Inc. - Covina CA
International Classification:
C40B 40/02
US Classification:
506 14
Abstract:
This invention provides methods for supplying a therapy for individuals exposed to radiation following a nuclear event, through the prospective establishment of an undesignated allogeneic stem cell bank with prospective HLA typing of healthy potential recipients.
Allogeneic Stem Cell Bank
US Patent:
2010032, Dec 23, 2010
Filed:
Apr 16, 2010
Appl. No.:
12/762118
Inventors:
Robert Chow - Arcadia CA, US
Lawrence D. Petz - Tarzana CA, US
Rubio R. Punzalan - Torrance CA, US
Denis O. Rodgerson - Malibu CA, US
Lawrence D. Petz - Tarzana CA, US
Rubio R. Punzalan - Torrance CA, US
Denis O. Rodgerson - Malibu CA, US
Assignee:
StemCyte, Inc. - Covina CA
International Classification:
C40B 40/02
US Classification:
506 14
Abstract:
This invention provides methods for supplying a therapy for individuals exposed to radiation following a nuclear event, through the prospective establishment of an undesignated allogeneic stem cell bank with prospective HLA typing of healthy potential recipients.
Allogeneic Stem Cell Bank
US Patent:
2008022, Sep 18, 2008
Filed:
Apr 28, 2008
Appl. No.:
12/110850
Inventors:
Robert Chow - Arcadia CA, US
Lawrence D. Petz - Tarzana CA, US
Rubio R. Punzalan - Torrance CA, US
Denis O. Rodgerson - Malibu CA, US
Lawrence D. Petz - Tarzana CA, US
Rubio R. Punzalan - Torrance CA, US
Denis O. Rodgerson - Malibu CA, US
Assignee:
STEMCYTE, INC. - COVINA CA
International Classification:
C12N 5/08
US Classification:
435372
Abstract:
This invention provides methods for supplying a therapy for individuals exposed to radiation following a nuclear event, through the prospective establishment of an undesignated allogeneic stem cell bank with prospective HLA typing of healthy potential recipients.